Abstract
The interplay between growing axons and the extracellular substrate is pivotal for directing axonal outgrowth during development and regeneration. Here we show an important role for the neuronal cell adhesion molecule α7β1 integrin during peripheral nerve regeneration. Axotomy led to a strong increase of this integrin on regenerating motor and sensory neurons, but not on the normally nonregenerating CNS neurons. α7 and β1 subunits were present on the axons and their growth cones in the regenerating facial nerve. Transgenic deletion of the α7 subunit caused a significant reduction of axonal elongation. The associated delay in the reinnervation of the whiskerpad, a peripheral target of the facial motor neurons, points to an important role for this integrin in the successful execution of axonal regeneration.
Changes in adhesion properties of transected axons and their environment are essential for regeneration. In the proximal part, the tips of the transected axons transform into growth cones that home onto the distal part of the nerve and enter the endoneurial tubes on their way toward the denervated tissue (Fawcett, 1992; Bisby, 1995). The distal part of the nerve undergoes Wallerian degeneration, a process involving the removal of the disconnected axons and their myelin sheaths from the associated Schwann cells. The denervated Schwann cells proliferate, attach to each other, and form bands of Büngner, which serve as a permissive substrate for axonal regrowth. These Schwann cells increase synthesis of adhesion molecules, such as L1 and laminin, which are inserted into their cell surface and the surrounding extracellular matrix (ECM) of the endoneurial tubes (Cornbrooks et al., 1983; Salonen et al., 1987;Martini, 1994). The process is mirrored by regenerating axons that upregulate receptors for endoneurial ECM molecules (Lefcort et al., 1992; Kloss et al., 1999).
The integrins are a large family of receptors for ECM molecules (Haas and Plow, 1994; Luckenbill-Edds, 1997) that consists of >20 different heterodimers formed by an α and a β subunit. Although many integrins, particularly β1 family members, are important for neurite outgrowth in vitro (Toyota et al., 1990; Letourneau et al., 1992; Tomaselli et al., 1993; Weaver et al., 1995; Condic and Letourneau, 1997), little is known about their physiological role during axonal regeneration in vivo. In this study we examined the regulation and function of the α7β1 integrin, a receptor for the basement membrane proteins laminins-1, -2, and -4 (Kramer et al., 1991; von der Mark et al., 1991; Yao et al., 1996). This integrin is mainly expressed in skeletal, cardiac, and smooth muscle (Song et al., 1992; Ziober et al., 1993; Martin et al., 1996), but it is also present in the developing brain (Van der Flier et al., 1995; Kil and Bronner-Fraser, 1996; Velling et al., 1996). In the adult nervous system, we now show that α7 is strongly upregulated in axotomized neurons in various injury models during peripheral nerve regeneration, but not after CNS injury. The deletion of the α7 subunit leads to an impairment in axonal outgrowth and a delayed target reinnervation of regenerating facial motoneurons.
MATERIALS AND METHODS
Animals and surgical procedures. Adult homozygous α7−/− and littermate controls (6-month-old) on a 129 Sv background used in this study were obtained from heterozygous crossings (Mayer et al., 1997). Normal adult C57Bl6 mice were obtained from Charles River (Sulzfeld, Germany). The animal experiments and care protocols were approved by the Regierung von Oberbayern (AZ 211-2531-10/93 and AZ 211-2531-37/97); all surgical procedures were performed under anesthesia with intraperitoneal injection of 150 μl of 2.5% avertin/10 gm of body weight. The facial nerve was cut at the foramen stylomastoideum, the hypoglossal nerve just before bifurcation, the vagal nerve at the midcervical level, and the sciatic nerve at the sciatic notch. For optic nerve crush, the eyeball was gently pushed forward, and the optic nerve was crushed repeatedly with fine tweezers for 10 sec. For a direct cerebral trauma, a 2.5-mm-deep, 2.5-mm-long, parasagittal cortical incision was performed on the dorsal forebrain (1.0 mm lateral of the midline, beginning 1.0 mm posterior of bregma, right side), which transected the cerebral cortex, the corpus callosum, and the fimbria fornix. The regeneration and reinnervation studies were performed after a facial nerve crush at the stylomastoid foramen.
Light microscopic immunohistochemistry. The animals were killed in ether, perfusion-fixed in 4% formaldehyde (FA) in PBS (4% FA–PBS), the tissue was removed, post-fixed in 1% FA–PBS for 2 hr, and cryoprotected with 30% sucrose overnight and frozen on dry ice, as previously described (Raivich et al., 1998a). Briefly, 20-μm-thick sections from brainstem, spinal cord, dorsal root ganglia, retina, septum, and cerebral cortex and 10 μm longitudinal sections of the facial and optic nerve were cut at −15°C, collected on gelatin-coated slides, spread in distilled water, fixed in formalin, defatted in acetone, and pretreated with 5% goat serum (Vector, Wiesbaden, Germany) in phosphate buffer (PB). The sections were incubated with primary polyclonal rabbit antibodies against α7 (1:10,000 dilution), galanin (1:400; Penninsula), calcitonin gene-related peptide (CGRP; 1:1000; Penninsula) or glial fibrillary acidic protein (GFAP; 1:5000; Dako, Hamburg, Germany), monoclonal rat antibodies against β1 (1:6000; Chemicon, Palo Alto, CA), αM (1:6000; Serotec, Oxford, UK), and MHC-1 (1:100; Dianova, Hamburg, Germany), or with a monoclonal Syrian hamster antibody against CD3 (1:3000; PharMingen, Hamburg, Germany). Then the sections were incubated with a biotinylated goat anti-rabbit, anti-rat (1:100; Vector) or anti-hamster (1:100; Dianova) secondary antibody, followed by incubation with the ABC reagent (Vector), visualization with diaminobenzidine/H2O2 (DAB; Sigma, Deisenhofen, Germany), dehydration in alcohol and xylene, and mounted with Depex (BDH Chemicals, Poole, UK). Double immunofluorescence was performed with a combination of the primary antibodies against α7 and β1, then biotinylated donkey anti-rabbit and FITC-conjugated goat anti-rat secondary antibodies (1:100; Dianova), followed by Texas Red–Avidin (1:100; Vector) and a FITC-donkey anti-goat tertiary antibody (Dianova), respectively, and scanned in a Leica (Nussloch, Germany) TCS 4D confocal laser microscope with a 10 and 100× objective (pinhole 30/100).
Electron microscopic immunohistochemistry. Perfusion with 40 ml of PBS and 10 mm MgCl2 (Mg–PBS) was followed by 100 ml of 0.5% glutaraldehyde and 4% FA in Mg–PBS and by 100 ml of 4% FA and Mg–PBS, nerve dissection, and a 2 hr immersion in 1% FA–PBS. Vibratome cross sections of 80 μm were obtained at the level of the growth front (5–6 mm distal to the crush), followed by pre-embedding immunohistochemistry as described (Möller et al., 1996). Briefly, free-floating sections were preincubated with goat serum for 4 hr, followed by incubation with the primary antibodies against α7- or β1-subunit. The biotinylated, secondary antibody was applied for 8 hr, followed by ABC reagent overnight and DAB staining, intensified with cobalt and nickel sulfates. After immunostaining, sections were fixed with glutaraldehyde, osmicated, embedded in Araldite (Fluka, Basel, Switzerland), cut (100 nm), counterstained with uranyl acetate and lead citrate, and examined in a Zeiss EM 10 electron microscope.
Quantification of light microscopic immunohistochemistry.Digital images from the stained sections were obtained using a Sony 3 CCD video camera (AVT-Horn, Aachen, Germany) and analyzed with the OPTIMAS 6.2 imaging system (Bethell). Luminosity values for the antibody staining intensity (SI) for each individual facial nucleus were determined using the Mean-SD algorithm as previously described (Kloss et al., 1999) and subsequent subtraction of the SI of the adjacent midline (n = 4 animals per time point).
Cell counts. To quantify microglial proliferation, the animals were injected with 200 μCi of [3H]thymidine (Amersham, Braunschweig, Germany) 3 d after facial nerve axotomy and 2 hr before killing by perfusion. Fixed brainstem sections were obtained as described, autoradiographed (Raivich et al., 1994), and labeled cells were counted for the whole facial motor nucleus (six sections per animal). GFAP-positive stellate astrocytes and CD3-positive lymphocytes were counted in the facial motor nuclei of two sections per animal.
Detection of α7β1 integrin mRNA. To study the mRNA, the facial motor nuclei, the gastrocnemius, and the heart muscle were excised immediately after killing and frozen on dry ice. Individual tissue samples were homogenized and processed using Tristar (Angewandte Gentechnologie Systeme AGS, Heidelberg, Germany) according to the manufacturer's protocol. RNA extracts (1 μg of total RNA) were reverse-transcribed with random hexamer primers using superscript II Moloney murine leukemia virus reverse transcriptase (Life Technologies, Eggenstein, Germany). Thirty-five cycle thermoenzymatic amplification of integrin mRNA was performed in a MJ Research DNA Engine (Peltier Thermocycler, Biometra, Göttingen, Germany), using the following primers: α7-sense 5′-tgctcagagatgcatcc-3′, α7-antisense 5′-caccggatgctcatcaggac-3′ and β1-sense 5′-ggcaacaatgaagctatcgt-3′, β1-antisense 5′-ccctcaacttcggattgac-3′. Amplification products were analyzed with gel electrophoresis.
Regeneration rate in the facial nerve. Four days after facial nerve crush, the animals were killed, followed by a brief, 5 min perfusion-fixation with 4% FA–PBS and then by a slow, 60 min perfusion with 1% FA–PBS, followed by immediate dissection and freezing on dry ice. Nerves were cut longitudinally, and the regenerating axons were visualized by immunostaining for galanin or CGRP. Every fifth section was used per antibody, with an interval of 50 μm, and the distance between the most distal-labeled growth cone and the crush site measured using light microscopic grid scaling. The average distance for each animal was calculated from four or five tissue sections.
Reinnervation of the whiskerpad. Under avertin anesthesia, a flat cut was performed under the skin of the right and left whiskerpad, a gelatin sponge (whiskerpad size, 1-mm-thick) filled with 15 μl of 4% FluoroGold (FG; Fluorochrome, Denver, CO) in H2O was inserted under the pad, removed after 20 min, and the wound tissue was rinsed with PBS before suture. The animals were perfused 48 hr after instillation of the retrograde tracer, and the brainstem sections were spread and dried for 10 min. The retrograde-labeled motoneurons within the facial motor nucleus (six sections per animal) were immediately counted under a fluorescence microscope with UV-light illumination. For illustrations (see Fig.5B) the sections were covered with Vectorshield (Vector) and scanned with a Leica TCS 4D confocal laser microscope (488 nm excitation, 590 nm longpass filter).
RESULTS
Regulation of α7 integrin subunit in the regenerating facial motor nucleus
Low levels of α7 were already observed in the normal brainstem (Fig. 1a,b). Transection of the facial nerve led to a massive increase of α7 immunoreactivity on the axotomized facial motoneurons (Fig. 1a–c). The increase of α7 was already apparent 1 d after axotomy, reached a maximum at day 7, and was followed by a decrease at the start of reinnervation at day 14. A very similar time course was previously shown for neuronal β1 immunoreactivity in the axotomized facial motor nucleus (Kloss et al., 1999). The specificity of the polyclonal rabbit anti-α7 antibody is shown by the disappearance of the α7 immunoreactivity on axotomized motoneurons in the α7-deficient mice (Fig. 1c). The mRNA for the α7 integrin subunits is known to undergo alternative splicing resulting in α7A and α7B isoforms; both isoforms associate with β1A and β1D integrin variants (Collo et al., 1993; Ziober et al., 1993; Van der Flier et al., 1995; Velling et al., 1996). However, only the mRNA for the α7B and β1A variants was detected both in the normal and axotomized facial motor nuclei by RT-PCR (Fig.1d).
Expression of α7β1 integrin in different central and peripheral injury models
The increase of α7 immunoreactivity on axotomized neurons was consistently present in different models of peripheral regeneration, but not after CNS injury. Four days after peripheral nerve injury, strong α7 staining was found on the axotomized motoneurons of the vagal and hypoglossal nuclei (Fig.2a,b). In the spinal cord, transection of the sciatic nerve caused an increase of α7 immunoreactivity on the spinal motoneurons and in the substantia gelatinosa (Fig. 2c). Dorsal rhizotomy abolished the staining in the dorsal but not the ventral horn, suggesting the localization of α7 on the primary sensory afferents in the substantia gelatinosa reacting to sciatic injury (data not shown). Axotomized dorsal root ganglia (DRG) showed a redistribution of α7 immunoreactivity (Fig. 2d). As in previous studies (Velling et al., 1996), normal, uninjured DRG showed strong α7 immunostaining on perineuronal satellite cells. This α7 immunostaining disappeared from the satellite cells after axotomy, but increased on the injured, small sensory neurons. Interestingly, small caliber sensory neurons show a particularly robust and rapid neurite outgrowth after axotomy (Brown et al., 1992). In the normal sciatic nerve, weak α7 was only detected in the perineurium. It increased strongly on the regenerating axons after crush (Fig. 2e).
In addition to the upregulation of the α7 subunit during regeneration, there was a parallel increase in immunostaining of the β1 subunit in the axotomized facial nucleus (see Fig. 7; Kloss et al., 1999). A similar increase was also present in regenerating hypoglossal, vagal, and spinal motoneurons and in the DRGs (data not shown).
Central axotomy did not induce the expression of the α7β1 integrin (Fig. 2f–j). In the retina, α7 (red) and β1 (green) colocalized on the retinal blood vessels (Fig. 2f,g, yellow profiles), similar to the presence of α7β1 on the cerebral blood vessels (Velling et al., 1996). However, both integrin subunits were absent from the retinal ganglion cells in the normal retina and 4 d after optic nerve crush (Fig. 2g, asterisks). Similar lack of α7 immunoreactivity was also observed in the crushed optic nerve (Fig. 2j). The local accumulation of αMβ2-positive macrophages was used to demarcate the lesion site (Fig. 2j, arrows) and served as a positive control.
Cortical incision with ensuing transection of the cerebral cortex and the underlying corpus callosum and fimbria fornix caused moderate α7 labeling on blood vessels around the wound (Fig. 2h, arrows) but not on the adjacent cortical neurons, including the widely projecting pyramidal cells in the third cortical layer. No α7 increase was observed on the septal neurons affected by the transection of the fimbria fornix (Fig. 2i).
In the distal part of the crushed facial nerve, the specific immunoreactivity to the cytoplasmic part of the α7 subunit was restricted to regenerating axons, with moderate submembranous staining of growth cones and strong immunoreactivity in fine axonal sprouts (Fig. 3a–c). This immunoreactivity was not detected on the associated Schwann cells (s), irrespective of the stage of axon and myelin (m) detachment. Immunoreactivity against the extracellular part of the β1 subunit (Fig. 3d) showed a cell surface staining of axons (n) and the Schwann cells (s). Specific β1 staining was most pronounced at the axon–axon (arrow) and axon–Schwann cell contacts (arrowhead).
Effects of α7 deficiency on axonal outgrowth and target reinnervation
To examine the functional role of α7 integrin during nerve regeneration, we compared the regeneration rate in α7-deficient mice and wild-type controls obtained from heterozygous crossings (Mayer et al., 1997). The facial nerve was crushed near the stylomastoid foramen (Fig. 4a, arrow), allowed to regenerate for 4 d, fixed, and sectioned longitudinally. Nerve sections were stained for the neuropeptides CGRP or galanin (Fig.4b), and the distance between the lesion site and the axonal growth front was measured with a light microscopic grid scaling. At day 4, the regeneration distance for the wild-type animals was 6.01 ± 0.35 mm for galanin- and 6.38 ± 0.29 for CGRP-immunoreactive axons (Fig. 4c; mean ± SE,n = 4 animals). A similar distance was also determined for heterozygous mice (5.96 ± 0.55 for galanin and 5.84 ± 0.55 mm for CGRP-positive axons, n = 2). The homozygous α7-deficient mice (n = 4) showed a significant, 33–35% reduction to 4.04 ± 0.24 mm for galanin- and 4.15 ± 0.48 mm and for CGRP-immunoreactive axons (p< 0.01 for each axonal marker; unpaired t test).
Reduced axonal regeneration could lead to a delay in the reinnervation of the peripheral target. We first examined the time course of reinnervation of the whiskerpad in normal, C57Bl6 mice (Fig.5a–c). FG was applied into the whiskerpads on the operated and unoperated side at different time points after facial nerve crush. The number of retrogradely labeled facial motoneurons was counted 2 d after application of the retrograde tracer (Fig. 5a,b) and compared to the unoperated side. No FG-labeled motoneurons were observed in the operated facial motor nucleus 7 d after the initial facial nerve crush. At day 9, there was a steep increase to 53 ± 10% of the contralaterally labeled neurons, which reached a maximum at day 14 (Fig.5c).
To determine the effects of α7 deficiency, the number of FG-labeled motoneurons in α7−/− and α7+/+ mice were compared 9 and 21 d after facial nerve crush (Fig. 5d). At day 9, wild-type animals showed a definite onset of reinnervation, with 25 ± 9% of the motoneurons labeled compared to that on the contralateral side. At the same time point, there were no FG-positive motoneurons in the operated facial motor nucleus of the α7−/− mice (p < 0.05 compared to wild-type animals, Wilcoxon test). This effect disappeared at day 21, with both animal groups showing a similar level of whiskerpad reinnervation.
Neuroglial response in the facial motor nucleus of normal and α7−/− mice
To determine if α7 deficiency also causes central changes in the injured facial motor nucleus that could impair regeneration, we examined characteristic markers of the neuroglial response using established histology and immunohistochemistry protocols (Raivich et al., 1994; Möller et al., 1996), shown in Figure6. The neuronal response was assessed with immunohistochemistry for the β1 integrin subunit, CGRP and galanin, neuropeptides in axotomized motoneurons (Möller et al., 1996; Klein et al., 1997), and the astrocyte response with the number of GFAP-immunoreactive, stellate figures. The early microglial activation was examined using autoradiography for [3H]thymidine-labeled, proliferating cells and immunoreactivity for the αMβ2-integrin. For the late response at day 14 we stained against MHC-1 on the microglia and counted the number of CD3-positive, infiltrating lymphocytes. As shown in Figures 6 and 7, there was no apparent difference for the neuronal peptides, early and late glial activation markers, and the recruitment of lymphocytes between the wild-type and the α7-deficient mice, either with light microscopy (Fig. 6) or at the quantitative level (Fig. 7). However, there was a clear and statistically significant increase in the neuronal staining for the β1 integrin subunit on the regenerating motoneurons in the α7−/− mice (Figs. 6, 7).
DISCUSSION
Expression of α7 and β1 integrin subunits is linked to peripheral nerve regeneration
The current study shows a highly consistent increase in α7β1 integrin immunoreactivity on axotomized motor and sensory neurons in different models of successful, peripheral regeneration. In contrast, this immunoreactivity for α7 and β1 subunits was not detected on intact and axotomized adult retinal ganglion cells, which normally do not regenerate. Similar lack of immunoreactivity was also observed for axotomized pyramidal cells and the septal neurons. Both the β1 integrin and different associated α-subunits are strongly expressed during brain and retinal development (Neugebauer and Reichardt, 1991;Tomaselli et al., 1993; Weaver et al., 1995; Kil and Bronner-Fraser, 1996; Velling et al., 1996). Previous studies also show an important role for β1 integrin family members in the neurite outgrowth of embryonic retinal ganglion cells (Neugebauer and Reichardt, 1991; Stone and Sakaguchi, 1996; Ivins et al., 1998; Treubert and Brummendorf, 1998). However, blocking antibodies against the β1 integrin subunit did not affect axonal regeneration in the adult retinal explants (Bates and Meyer, 1997). In view of the current findings, high levels of α7 and β1 integrin expression appear not to be linked to axotomy per se but to a successful type of axonal regeneration in vivo.
Quantitative methods to measure axonal regeneration
In the current study we used two separate methods to compare the speed of nerve regeneration in normal and α7 knock-out mice: at the early phase of axonal outgrowth and at the onset of target reinnervation. In the first method, we immunostained longitudinal nerve sections against the axon-specific neuropeptides CGRP and galanin (Gray et al., 1992). These peptides are synthesized in two apparently nonoverlapping motoneuron populations (Moore, 1989) and are transported anterogradely into the axonal growth cones. Because the facial nerve is almost purely motoric, the staining of the growth front is specific to motor axons. Four days after injury, the growth distance in normal mice was 6.01 ± 0.35 mm for the galanin- and 6.38 ± 0.29 mm for the CGRP-positive motor axons. Previous studies using electrophysiological and autoradiographic techniques revealed a regeneration rate of motor and sensory neurons of ∼4 mm/d (Forman and Berenberg, 1978; McQuarrie et al., 1978; Bisby and Keen, 1985; Chen and Bisby, 1993). However, they also showed an initial delay of ∼2 d (Forman and Berenberg, 1978). If this delaying effect was included, the resulting regeneration rate in the current study would be ∼3 mm/d.
The second method addressed the effects on the late stage of axonal regeneration, at the onset of target reinnervation. Here, we applied FG to the whiskerpads at different time points after crush (Hirota et al., 1996). The observed onset of FG uptake by reinnervating motor axons after day 7 corresponds well with the beginning of whiskerpad movements at day 9 (Chen and Bisby, 1993). Because the total distance between crush site and whiskerpad is ∼18 mm, the axons appear to grow at a rate of 3.6 mm/d, again assuming an initial delay of 48 hr. The slightly lower regeneration rate at the early phase of axonal outgrowth might be attributable to the previously reported suboptimal growth speed during the first days after injury (Forman and Berenberg, 1978). Overall, the current data on the speed of axonal outgrowth are in agreement with previous studies. Importantly, both methods used produce similar results and show little intragroup variation, allowing us to observe statistically significant changes in relatively small groups of animals.
α7 integrin subunit plays an important role in the regenerating facial nerve
Both α7 and β1 integrin subunits were present on growing axons in the distal part of the crushed facial nerve and participated in contacts among axons and between axons and Schwann cells. The importance of the α7β1 integrin is also underlined by transgenic experiments. α7 null mice show a reduced rate of axonal outgrowth and a delay in the reinnervation of the whiskerpad, a peripheral target of facial motoneurons. This effect of α7 deficiency was present in two nonoverlapping populations of facial motoneurons that express galanin or CGRP (Moore, 1989), pointing to a rather general role of this adhesion molecule in promoting regeneration.
The present experiments clearly suggest a peripheral site of α7β1 action. The α7β1 integrin is a specific receptor for laminin-1 (α1β1γ1), laminin-2 (α2β1γ1), and laminin-4 (α2β2γ1) (Kramer et al., 1991; von der Mark et al., 1991; Yao et al., 1996). The laminin-2 and laminin-4 isoforms are present in the normal peripheral nerve (Kuecherer-Ehret et al., 1990; Hsiao et al., 1993), and their synthesis is increased after injury (Kuecherer-Ehret et al., 1990; Doyu et al., 1993; LeBeau et al., 1994). At the ultrastructural level, laminin immunoreactivity is present on the Schwann cell surface and the basal membranes both facing the regenerating axons (Kuecherer-Ehret et al., 1990; Wang et al., 1992; Ide, 1996). Immune neutralization of laminin inhibits axonal growth inside the basal lamina scaffolds in peripheral nerves (Ide, 1996); a similar effect was observed using antibodies specific for the α2-laminin chain (Agius and Cochard, 1998). Thus, the α2β1γ1 and α2β2γ1 laminin isoforms are most likely, functionally active targets for the axonal α7β1 integrin in the regenerating peripheral nerve. In contrast to the periphery, antibodies against laminin failed to inhibit neurite outgrowth on the immature spinal cord substrate (Agius et al., 1996).
Absence of the α7 integrin subunit causes only a partial reduction in the speed of nerve fiber regeneration. This suggests the presence of additional axonal molecules promoting axon outgrowth, leading to a partial functional compensation for the α7 deficiency. The particularly strong increase of the β1 subunit after axotomy in the α7−/− mice clearly supports such a compensatory mechanism via other associated α-subunits (Toyota et al., 1990; Condic and Letourneau, 1997). Other potential groups include cadherins (Seilheimer and Schachner, 1988; Doherty et al., 1990) and the Ig superfamily of cell adhesion molecules (Seilheimer and Schachner, 1988; Doherty et al., 1990; Martini, 1994). Here, a conditional gene-targeting approach to these molecules in axotomized neurons will shed more light into the mechanisms regulating cell adhesion and the overall process of successful axonal regeneration.
α7 integrin deficiency does not affect the central neuroglial response
In contrast to axonal regeneration, the absence of the α7 integrin subunit did not lead to a change of the cellular response in the axotomized facial nucleus, the affected part of the CNS. Nerve transection is known to cause a pronounced cellular response at two different sites: distal to the site of axotomy, but also in and around the cell body of the affected neurons. Distal to the lesion, the nerve undergoes Wallerian degeneration, followed by the outgrowth of the sprouting axons into the distal nerve toward the peripheral tissues (Fawcett, 1992; Bisby, 1995).
At the level of the neuronal cell body, injured motoneurons increase protein synthesis, including adhesion molecules (Martini and Schachner, 1988; Möller et al., 1996; Jones et al., 1997) and neuropeptides (Raivich et al., 1995). Reactive astrocytes upregulate cytoskeletal proteins like GFAP and convert to a stellate type (Graeber and Kreutzberg, 1986; Raivich et al., 1999). Activated microglial cells proliferate, upregulate activation markers such as αMβ2 integrin (Raivich et al., 1994), and transform after neuronal cell death into phagocytes that degrade neuronal debris (Torvik and Skjorten, 1971;Kreutzberg, 1996; Klein et al., 1997). The upregulation of antigen presenting molecule MHC1 and costimulatory factors such as B7.2 and ICAM-1 (Raivich et al., 1998a; Werner et al., 1998; Bohatschek et al., 1999) on these phagocytotic cells coincides with the recruitment of lymphocytes (Raivich et al., 1998a).
Although these different aspects of glial activation have been thought to support nerve regeneration (Streit, 1993), recent studies have put some doubt on this notion. Thus, the cytostatic ablation of proliferating microglia with cytosine-arabinoside does not affect the speed of axonal regeneration in the hypoglossal nerve (Svensson and Aldskogius, 1993). A similar absence of effect on the regenerating facial nerve is also observed in mice that are deficient for the macrophage-colony stimulating factor with a severe reduction of microglial activation and proliferation (A. Werner and G. Raivich, unpublished observations). An alternative hypothesis is that neuronal injury leads to two separate sets of effects: it induces a neuronal regeneration program and at the same time, a central glial activation, with little effect of the latter on the former. This glial response was recently suggested to be part of the anti-infectious repertoire of the injured CNS, which could help to protect the damaged neurons and the surrounding environment from possible infection (Raivich et al., 1999). Interestingly, the data provided by the current study support the notion of two separate, relatively independent sets of effects. In addition to the reduction in axonal regeneration, the lack of the α7 subunit also causes a strong increase in the level of the associated neuronal β1 integrin. This upregulation of β1 may be part of a compensatory mechanism, to ensure successful regeneration in the injured peripheral nerve. Surprisingly, the contralateral, upoperated facial nucleus shows normal levels of β1 immunoreactivity both in the wild-type and the α7−/− mice, suggesting that the effect of α7 deficiency on the expression of β1 is triggered by the neuronal regeneration program.
In contrast, the absence of α7 did not appear to affect the response to injury by glia or lymphocytes, suggesting that the immune surveillance of the injured CNS is unaffected by the absence of the α7 subunit. At present, little is known about the neuronal trigger that initiates these central reactions. However, the absence of the α7 integrin subunit did not affect the expression of neuronal peptides like CGRP or galanin. In vitro, these neuropeptides play an important role in the activation of astrocytes and microglia (Lazar et al., 1991; Priller et al., 1998) and might be central mediators of the glial response.
In summary, the current study suggests that the α7β1 integrin is an important mediator of axonal regeneration. Axotomy leads to a highly consistent increase of α7β1 integrin immunoreactivity on axotomized motor and sensory neurons in different models of successful regeneration. Both the α7 and β1 subunit are concentrated on growth cones in the regenerating nerve, and the transgenic deletion of the α7 subunit led to a reduced rate of axonal elongation in the axotomized nerve and a delayed target reinnervation. Moreover, the lack of changes in the central neuroglial response to injury clearly indicates a peripheral site of action for this cell adhesion molecule in the interaction with the extracellular matrix in the injured peripheral nerve.
Footnotes
This work was supported by grants 01KO9401/3 and 01KO9703/3 of the Bundesministerium für Bildung und Forschung. We thank Andrea Koppius, Dietmute Büringer, and Karin Brückner for their expert technical assistance and Dr. Jim Chalcroft for his help with digital photography.
Correspondence should be addressed to Dr. Gennadij Raivich, Department of Neuromorphology, Max-Planck-Institute of Neurobiology, Am Klopferspitz 18a 82152 Martinsried, Germany. E-mail:Raivich{at}neuro.mpg.de.